AbbVie(DE:4AB)
€262.20-0.40 (-0.15%)
DE:4AB
AbbVie ownership
€262.20
At close:-0.40 (-0.15%)
AbbVie (4AB) Ownership - Who Owns AbbVie?
28 Followers
AbbVie (4AB) Ownership Overview
- 0.06% Insiders
- 20.91% Mutual Funds
- 6.68% Other Institutional Investors
- 23.64% ETFs
- 48.72% Public Companies and Individual Investors
The ownership structure of AbbVie (DE:4AB) stock is a mix of institutional, retail, and individual investors. Approximately 51.22% of the company’s stock is owned by Institutional Investors, 0.06% is owned by Insiders, and 48.72% is owned by Public Companies and Individual Investors.
The ownership structure of AbbVie (DE:4AB) stock is a mix of institutional, retail, and individual investors. Approximately 51.22% of the company’s stock is owned by Institutional Investors, 0.06% is owned by Insiders, and 48.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 17, 2026 | Nicholas Donoghoe | $8,177,500 | |
| Mar 05, 2026 | David Ryan Purdue | $1,221,519 | |
| Mar 02, 2026 | Perry C Siatis | $7,821,937 | |
| Feb 26, 2026 | Perry C Siatis | $5,147,630 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Esl Trust Services, Llc | €59,407 | |
| Dec 31, 2025 | Manning & Napier Advisors Llc | €81,342 | |
| Dec 31, 2025 | Howard Hughes Medical Institute | €87,054 | |
| Dec 31, 2025 | Carolina Wealth Advisors, Llc | €138,236 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 159,875,842 | Institution | 9.04% | 46,516,195,982 |
| BlackRock, Inc. | 149,488,412 | Institution | 8.46% | 43,493,952,448 |
| Vanguard Index Funds | 120,753,956 | Institution | 6.83% | 35,133,605,006 |
| Ishares | 87,450,635 | Institution | 4.95% | 25,443,937,155 |
| Spdr | 73,642,339 | Institution | 4.17% | 21,426,385,817 |
| Fidelity Concord Street Trust | 30,776,812 | Institution | 1.74% | 8,954,575,005 |
| Amundi | 16,368,041 | Institution | 0.93% | 4,762,314,265 |
| Vanguard Specialized Funds | 14,196,502 | Institution | 0.80% | 4,130,500,650 |
| Invesco | 12,581,797 | Institution | 0.71% | 3,660,699,001 |
| Jpmorgan | 12,272,993 | Institution | 0.69% | 3,570,851,859 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 120,753,956 | Institution | 6.83% | 35,133,605,006 |
| Fidelity Concord Street Trust | 30,776,812 | Institution | 1.74% | 8,954,575,005 |
| Vanguard Specialized Funds | 14,196,502 | Institution | 0.80% | 4,130,500,650 |
| American Mutual Fund | 11,145,520 | Institution | 0.63% | 3,242,811,335 |
| Vanguard Institutional Index Funds | 10,436,837 | Institution | 0.59% | 3,036,618,599 |
| Capital Income Builder | 10,055,634 | Institution | 0.57% | 2,925,706,824 |
| Washington Mutual Investors Fund | 9,627,943 | Institution | 0.54% | 2,801,269,272 |
| Vanguard World Fund | 9,270,798 | Institution | 0.52% | 2,697,357,220 |
| Fidelity Salem Street Trust | 8,828,930 | Institution | 0.50% | 2,568,794,841 |
| Vanguard Whitehall Funds | 7,157,105 | Institution | 0.40% | 2,082,374,014 |
FAQ
Who Owns AbbVie (DE:4AB)?
According to the latest TipRanks data, approximately 51.22% of the company's stock is held by institutional investors, 0.06% is held by insiders, and 48.72% is held by public companies and individual investors.
What percentage of AbbVie (DE:4AB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.22% of AbbVie (DE:4AB) stock is held by institutional investors: 20.91% by mutual funds, 23.64% by ETFs and 6.68% by other institutional investors.
What percentage of AbbVie (DE:4AB) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.72% of AbbVie (DE:4AB) stock is held by public companies and individual investors.
Who owns the most shares of AbbVie (DE:4AB)?
Vanguard owns the most shares of AbbVie (DE:4AB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
